CDC Telebriefing: Update on Pulmonary Disease Associated with E-cigarettes
Embargoed Until: Friday, September 6, 2019, 1:00 p.m. ET
Contact: Media Relations
The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and state partners will give updates on the investigation into cases of pulmonary disease among people who use e-cigarettes, and discuss initial findings published Friday.
Ileana Arias, PhD, acting deputy director, Non-Infectious Diseases, CDC
Dana Meaney-Delman, MD, MPH, incident manager, CDC 2019 Lung Injury Response
Daniel Fox, MD, Pulmonary & Critical Care Medicine, WakeMed Health & Hospitals (NC)
Jonathan Meiman, MD, chief medical officer, Wisconsin Department of Health Services
Jennifer Layden, MD, PhD, chief medical officer and state epidemiologist, Illinois Department of Public Health
Mitch Zeller, JD, director, Center for Tobacco Products, FDA
Brian King, PhD, MPH, deputy director, Research Translation, Office on Smoking and Health, CDC
Friday, September 6, at 12 p.m. ET
PASSCODE: CDC Media
If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question.
You may queue up at any time. You will hear a tone to indicate your question is pending.
A transcript and audio will be available following the briefing at CDC’s web site: www.cdc.gov/media.
CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.